Somatostatin Analogs for Pancreatic Neuroendocrine Tumors: Any Benefit When Ki-67 Is ≥10%?
Merola E, Alonso Gordoa T, Zhang P, Al-Toubah T, Pellè E, Kolasińska-Ćwikła A, Zandee W, Laskaratos F, de Mestier L, Lamarca A, Hernando J, Cwikla J, Strosberg J, de Herder W, Caplin M, Cives M, van Leeuwaarde R.
Merola E, et al. Among authors: pelle e.
Oncologist. 2021 Apr;26(4):294-301. doi: 10.1002/onco.13633. Epub 2020 Dec 29.
Oncologist. 2021.
PMID: 33301235
Free PMC article.